MorphECOS - Evaluation of the Influence of Fatigue and Sleep on the Performance of 2nd Cycle Medical Students (OSCE) (MorphECOS)

April 29, 2025 updated by: Evan GOUY, Claude Bernard University

MorphECOS - Evaluation of the Influence of Fatigue and Sleep on the Performance of 2nd Cycle Medical Students (OSCE): a Single-centre Observational Study

Objective and Structured Clinical Examinations (OSCEs) has been incorporated recently in the certification process as a final national undergraduate ranking examination. This exam is a challenge for medical students.

The aim of this study is to better characterise the population of students taking the OSCEs on the subject of sleep and fatigue and to assess whether these factors have an impact on their performance in the OSCEs.

Study Overview

Study Type

Observational

Enrollment (Actual)

619

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69003
        • Claude Bernard University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

2nd cycle médical program

Description

Inclusion Criteria:

  • Subjects of legal age, enrolled in the 2nd cycle médical program at the Lyon Est Faculty of Medicine (Claude Bernard Lyon 1 University), taking part in the annual session (February or March 2025) of the faculty's OSCEs and having agreed to participate by completing and signing the dedicated written consent form.

Exclusion Criteria:

  • abstenteism or Premature end to the OSCE session.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
5th year of medical curriculum
6th year of medical curriculum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PERFORMANCE
Time Frame: obtained seven days after the objectif structured clinical examination
Score at the objectif structured clinical examination exam from 0 minimum to 200 points maximum
obtained seven days after the objectif structured clinical examination

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Significant difference in student performance per station and per item
Time Frame: obtained seven days after the objectif structured clinical examination
Significant difference in student performance per station and per item
obtained seven days after the objectif structured clinical examination
Significant difference in Visual Analog Scale response according to the different profiles
Time Frame: Two times : 1 hour before and 1 hour after the OSCE session
Significant difference in Visual Analog Scale response according to the different profiles
Two times : 1 hour before and 1 hour after the OSCE session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 27, 2025

Primary Completion (Actual)

March 20, 2025

Study Completion (Actual)

March 20, 2025

Study Registration Dates

First Submitted

February 3, 2025

First Submitted That Met QC Criteria

April 29, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Not provided for in the protocol.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Subscribe